As per Intent Market Research, the Compression Therapy Market was valued at USD 4.4 billion in 2024-e and will surpass USD 7.2 billion by 2030; growing at a CAGR of 8.6% during 2025 - 2030.
The compression therapy market is experiencing steady growth due to its effectiveness in managing various circulatory disorders, post-surgical recovery, and sports injuries. Increasing cases of chronic venous insufficiency (CVI), deep vein thrombosis (DVT), and lymphedema have driven the demand for compression garments, pumps, and bandages. Additionally, the rising number of orthopedic injuries and sports-related conditions has further boosted market expansion. With growing awareness about non-invasive treatment options, compression therapy has become a preferred choice for patients and healthcare professionals alike.
Technological advancements in compression therapy products, such as smart compression devices with pressure monitoring and gradient compression techniques, have improved treatment outcomes. The increasing adoption of home-based care, particularly for venous disorders and post-surgical recovery, is also fueling market growth. As the global population ages and the prevalence of chronic diseases rises, the demand for effective compression therapy solutions is expected to surge.
Compression Garments Lead the Market Due to Their Versatility and Widespread Use
The compression garments segment holds the largest market share, driven by their widespread use in treating venous disorders, lymphedema, and sports injuries. Compression stockings, sleeves, and bandages are commonly recommended for managing circulation-related conditions by improving blood flow and reducing swelling. The increasing incidence of varicose veins and post-thrombotic syndrome has significantly contributed to the demand for compression garments.
Advancements in material technology, including moisture-wicking and antibacterial fabrics, have improved patient comfort and compliance. Additionally, the growing trend of preventive healthcare has led to a rise in the use of compression garments among athletes and individuals with occupations requiring prolonged standing or sitting. As patient preference shifts toward convenient and cost-effective treatment options, compression garments will continue to dominate the market.
.JPG)
Static Compression Therapy is the Preferred Technology Due to Its Simplicity and Effectiveness
Static compression therapy holds the largest market share, as it is widely used for managing venous and lymphatic disorders. This form of therapy involves applying constant pressure through garments, bandages, or wraps, promoting blood circulation and reducing swelling. Static compression is particularly beneficial for patients with conditions such as varicose veins, lymphedema, and post-surgical edema.
The ease of use and affordability of static compression products make them a preferred choice for both healthcare professionals and patients. Additionally, advancements in fabric technology have enhanced the comfort and durability of compression garments. While dynamic compression therapy is gaining traction in specialized treatments, static compression remains the dominant choice due to its effectiveness and accessibility.
Venous Leg Ulcers Dominate the Application Segment Due to High Prevalence and Treatment Demand
Venous leg ulcers account for the largest share of the compression therapy market, as they are one of the most common chronic wounds affecting individuals with venous insufficiency. Compression therapy is the standard treatment for venous leg ulcers, as it helps improve venous return, reduce swelling, and accelerate wound healing. The rising geriatric population and increasing prevalence of diabetes and obesity—both of which are risk factors for venous ulcers—have further driven market growth.
The integration of advanced wound care with compression therapy, such as multilayer compression bandaging and adjustable compression wraps, has improved treatment outcomes. Healthcare providers are also increasingly focusing on patient education and compliance to enhance long-term management of venous ulcers. As the burden of chronic wounds continues to rise, the demand for compression therapy in venous leg ulcer treatment is expected to remain strong.
Hospitals Lead the End-User Segment Due to High Patient Admissions and Advanced Treatment Facilities
Hospitals represent the largest end-user segment in the compression therapy market, as they handle a significant number of patients requiring post-surgical recovery, wound care, and chronic disease management. Hospitals have access to advanced compression therapy devices, including intermittent pneumatic compression pumps, which are commonly used in DVT prevention and post-operative care.
The increasing number of surgical procedures, particularly orthopedic and vascular surgeries, has contributed to the demand for compression therapy in hospital settings. Additionally, hospitals are incorporating digital compression therapy systems that provide real-time pressure monitoring and customized treatment plans. While home care settings are gaining traction due to the growing preference for self-management, hospitals will continue to dominate the market due to their comprehensive treatment capabilities.
North America Leads the Market Due to High Awareness and Advanced Healthcare Infrastructure
North America holds the largest share of the compression therapy market, primarily due to the high prevalence of chronic venous diseases, lymphedema, and post-surgical recovery cases. The region's advanced healthcare infrastructure, combined with strong reimbursement policies, has facilitated the widespread adoption of compression therapy products. Additionally, the presence of key market players and ongoing technological advancements have further strengthened market growth.
The increasing participation in sports and fitness activities has also driven the demand for compression garments in North America. Athletes and fitness enthusiasts are increasingly using compression sleeves, socks, and braces to enhance performance and prevent injuries. With continuous product innovation and expanding application areas, North America is expected to maintain its leading position in the compression therapy market.
.JPG)
Competitive Landscape and Key Players
The compression therapy market is highly competitive, with key players including 3M, BSN Medical (Essity), SIGVARIS Group, Medtronic, Paul Hartmann AG, and Bio Compression Systems. These companies are investing in research and development to introduce advanced compression therapy solutions, such as wearable smart compression devices and customizable pressure garments.
Strategic collaborations, product launches, and acquisitions are shaping the competitive landscape. Companies are also focusing on expanding their distribution networks and strengthening their presence in emerging markets. As demand for non-invasive and effective treatment options continues to rise, innovation and product differentiation will play a crucial role in gaining a competitive edge in the market.
List of Leading Companies:
- 3M Company
- Medtronic plc
- SIGVARIS Group
- BSN Medical (Essity)
- medi GmbH & Co. KG
- Paul Hartmann AG
- Tactile Medical
- Julius Zorn GmbH (Juzo)
- Bio Compression Systems, Inc.
- Gottfried Medical, Inc.
- ArjoHuntleigh (Getinge Group)
- DJO Global, Inc.
- Thuasne Group
- Lohmann & Rauscher
- Cardinal Health
Recent Developments:
- In January 2025, 3M introduced an advanced compression bandage with enhanced breathability for wound care.
- In December 2024, Medtronic launched a new AI-powered compression pump for lymphedema management.
- In November 2024, SIGVARIS Group expanded its compression stocking product line with new gradient compression designs.
- In October 2024, BSN Medical partnered with leading hospitals to implement smart compression therapy solutions.
- In September 2024, medi GmbH & Co. KG unveiled a new range of sports compression wear for injury prevention and recovery.
Report Scope:
|
Report Features |
Description |
|
Market Size (2024-e) |
USD 4.4 billion |
|
Forecasted Value (2030) |
USD 7.2 billion |
|
CAGR (2025 – 2030) |
8.6% |
|
Base Year for Estimation |
2024-e |
|
Historic Year |
2023 |
|
Forecast Period |
2025 – 2030 |
|
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
|
Segments Covered |
Compression Therapy Market By Product Type (Compression Garments, Compression Pumps, Compression Tapes), By Technology (Static Compression Therapy, Dynamic Compression Therapy), By Application (Venous Leg Ulcers, Lymphedema, Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency, Sports Injury Recovery), By End User (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), Home Care Settings) |
|
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
|
Major Companies |
3M Company, Medtronic plc, SIGVARIS Group, BSN Medical (Essity), medi GmbH & Co. KG, Paul Hartmann AG, Tactile Medical, Julius Zorn GmbH (Juzo), Bio Compression Systems, Inc., Gottfried Medical, Inc., ArjoHuntleigh (Getinge Group), DJO Global, Inc., Thuasne Group, Lohmann & Rauscher, Cardinal Health |
|
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
Frequently Asked Questions
The Compression Therapy Market was valued at USD 4.4 billion in 2024-e and is expected to grow at a CAGR of over 8.6% from 2025 to 2030.
Rising cases of venous disorders, sports injuries, and post-surgical swelling, along with technological advancements.
Static compression applies consistent pressure, while dynamic compression alternates pressure levels to improve circulation.
It helps reduce swelling, improve blood circulation, and prevent complications like venous ulcers.
Lymphedema, deep vein thrombosis, chronic venous insufficiency, and post-operative recovery.
|
1. Introduction |
|
1.1. Market Definition |
|
1.2. Scope of the Study |
|
1.3. Research Assumptions |
|
1.4. Study Limitations |
|
2. Research Methodology |
|
2.1. Research Approach |
|
2.1.1. Top-Down Method |
|
2.1.2. Bottom-Up Method |
|
2.1.3. Factor Impact Analysis |
|
2.2. Insights & Data Collection Process |
|
2.2.1. Secondary Research |
|
2.2.2. Primary Research |
|
2.3. Data Mining Process |
|
2.3.1. Data Analysis |
|
2.3.2. Data Validation and Revalidation |
|
2.3.3. Data Triangulation |
|
3. Executive Summary |
|
3.1. Major Markets & Segments |
|
3.2. Highest Growing Regions and Respective Countries |
|
3.3. Impact of Growth Drivers & Inhibitors |
|
3.4. Regulatory Overview by Country |
|
4. Compression Therapy Market, by Product Type (Market Size & Forecast: USD Million, 2023 – 2030) |
|
4.1. Compression Garments |
|
4.1.1. Compression Bandages |
|
4.1.2. Compression Stockings |
|
4.1.3. Compression Braces |
|
4.1.4. Others |
|
4.2. Compression Pumps |
|
4.2.1. Pneumatic Compression Pumps |
|
4.2.2. Non-Pneumatic Compression Pumps |
|
4.2.3. Others |
|
4.3. Compression Tapes |
|
4.4. Others |
|
5. Compression Therapy Market, by Technology (Market Size & Forecast: USD Million, 2023 – 2030) |
|
5.1. Static Compression Therapy |
|
5.2. Dynamic Compression Therapy |
|
5.3. Others |
|
6. Compression Therapy Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
|
6.1. Venous Leg Ulcers |
|
6.2. Lymphedema |
|
6.3. Deep Vein Thrombosis (DVT) |
|
6.4. Chronic Venous Insufficiency |
|
6.5. Sports Injury Recovery |
|
6.6. Others |
|
7. Compression Therapy Market, by End User (Market Size & Forecast: USD Million, 2023 – 2030) |
|
7.1. Hospitals |
|
7.2. Clinics |
|
7.3. Ambulatory Surgical Centers (ASCs) |
|
7.4. Home Care Settings |
|
7.5. Others |
|
8. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
|
8.1. Regional Overview |
|
8.2. North America |
|
8.2.1. Regional Trends & Growth Drivers |
|
8.2.2. Barriers & Challenges |
|
8.2.3. Opportunities |
|
8.2.4. Factor Impact Analysis |
|
8.2.5. Technology Trends |
|
8.2.6. North America Compression Therapy Market, by Product Type |
|
8.2.7. North America Compression Therapy Market, by Technology |
|
8.2.8. North America Compression Therapy Market, by Application |
|
8.2.9. North America Compression Therapy Market, by End User |
|
8.2.10. By Country |
|
8.2.10.1. US |
|
8.2.10.1.1. US Compression Therapy Market, by Product Type |
|
8.2.10.1.2. US Compression Therapy Market, by Technology |
|
8.2.10.1.3. US Compression Therapy Market, by Application |
|
8.2.10.1.4. US Compression Therapy Market, by End User |
|
8.2.10.2. Canada |
|
8.2.10.3. Mexico |
|
*Similar segmentation will be provided for each region and country |
|
8.3. Europe |
|
8.4. Asia-Pacific |
|
8.5. Latin America |
|
8.6. Middle East & Africa |
|
9. Competitive Landscape |
|
9.1. Overview of the Key Players |
|
9.2. Competitive Ecosystem |
|
9.2.1. Level of Fragmentation |
|
9.2.2. Market Consolidation |
|
9.2.3. Product Innovation |
|
9.3. Company Share Analysis |
|
9.4. Company Benchmarking Matrix |
|
9.4.1. Strategic Overview |
|
9.4.2. Product Innovations |
|
9.5. Start-up Ecosystem |
|
9.6. Strategic Competitive Insights/ Customer Imperatives |
|
9.7. ESG Matrix/ Sustainability Matrix |
|
9.8. Manufacturing Network |
|
9.8.1. Locations |
|
9.8.2. Supply Chain and Logistics |
|
9.8.3. Product Flexibility/Customization |
|
9.8.4. Digital Transformation and Connectivity |
|
9.8.5. Environmental and Regulatory Compliance |
|
9.9. Technology Readiness Level Matrix |
|
9.10. Technology Maturity Curve |
|
9.11. Buying Criteria |
|
10. Company Profiles |
|
10.1. 3M Company |
|
10.1.1. Company Overview |
|
10.1.2. Company Financials |
|
10.1.3. Product/Service Portfolio |
|
10.1.4. Recent Developments |
|
10.1.5. IMR Analysis |
|
*Similar information will be provided for other companies |
|
10.2. Medtronic plc |
|
10.3. SIGVARIS Group |
|
10.4. BSN Medical (Essity) |
|
10.5. medi GmbH & Co. KG |
|
10.6. Paul Hartmann AG |
|
10.7. Tactile Medical |
|
10.8. Julius Zorn GmbH (Juzo) |
|
10.9. Bio Compression Systems, Inc. |
|
10.10. Gottfried Medical, Inc. |
|
10.11. ArjoHuntleigh (Getinge Group) |
|
10.12. DJO Global, Inc. |
|
10.13. Thuasne Group |
|
10.14. Lohmann & Rauscher |
|
10.15. Cardinal Health |
|
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Compression Therapy Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Compression Therapy Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
.png)
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the Automated Breast Ultrasound Systems ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Compression Therapy Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
.jpg)
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.